Intra-Cellular Therapies ITCI

Annual report 2024
added 02-21-2025

Intra-Cellular Therapies DIO Ratio 2011-2026 | ITCI

Quarterly DIO Ratio Intra-Cellular Therapies

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.67 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
4.67 K	4.67 K	4.67 K

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Alnylam Pharmaceuticals ALNY	43.5	$ 330.34	3.6 %	$ 43.3 B	USA
	CollPlant Biotechnologies Ltd. CLGN	130	$ 0.44	-16.64 %	$ 5.04 M	Israel
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Catalyst Pharmaceuticals CPRX	119	$ 24.98	1.17 %	$ 3.05 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Crinetics Pharmaceuticals CRNX	343	$ 37.7	1.26 %	$ 3.55 B	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aquestive Therapeutics AQST	120	$ 4.09	-0.97 %	$ 437 M	USA
	DBV Technologies S.A. DBVT	332	$ 20.36	-3.32 %	$ 2.84 B	France
	Dyadic International DYAI	161	$ 0.87	-2.8 %	$ 31.5 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain